These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4880407)

  • 21. Positive Hemoccult reactions after oral iron: true or false?
    Gastroenterology; 1983 Mar; 84(3):670-2. PubMed ID: 6822337
    [No Abstract]   [Full Text] [Related]  

  • 22. [Double-blind trial of tiapride versus placebo in patients with sub-perennial idiopathic headache].
    Cerbo R; Casacchia M; Boni B; Corona R
    Sem Hop; 1982 Dec; 58(48):2839-44. PubMed ID: 6302851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paper tests for occult blood in faeces and some observations on the fate of swallowed red cells.
    HUNTSMAN RG; LIDDELL J
    J Clin Pathol; 1961 Jul; 14(4):436-40. PubMed ID: 13716912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability.
    Maurer JM; Schellekens RC; van Rieke HM; Stellaard F; Wutzke KD; Buurman DJ; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG
    J Control Release; 2013 Dec; 172(3):618-24. PubMed ID: 24096020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A paper test for occult blood in faeces using ortho-dianisidine.
    Bird R; Burr RG
    J Clin Pathol; 1968 Sep; 21(5):675-6. PubMed ID: 5697373
    [No Abstract]   [Full Text] [Related]  

  • 26. [Oral iron therapy. Bioavailability and therapeutic effectiveness of ferrous iron in effervescent tablets in posthemorrhagic iron deficiency anemia].
    Kaltwasser JP; Schwarz-van de Sand W
    Dtsch Med Wochenschr; 1989 Aug; 114(31-32):1188-95. PubMed ID: 2666080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind comparison of effects of aspirin and namoxyrate on pH of gastric secretions, fecal blood loss, serum iron, and iron-binding capacity in normal volunteers.
    Rider JA; DeFelice EA; Puletti EJ; Moeller HC
    Curr Ther Res Clin Exp; 1965 Oct; 7(10):633-8. PubMed ID: 4954889
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the use of benzidine for checking of medical instrumentation for concealed blood].
    Gerasun BA; Shlaffer PI
    Lab Delo; 1969; 5():315-6. PubMed ID: 4185273
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1,000 patients.
    Liguori L
    Int J Clin Pharmacol Ther Toxicol; 1993 Mar; 31(3):103-23. PubMed ID: 8468108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Does oral iron therapy interfere with the hemoccult test?].
    Souverijn JH
    Ned Tijdschr Geneeskd; 1986 Jan; 130(1):32. PubMed ID: 3951578
    [No Abstract]   [Full Text] [Related]  

  • 33. [Determination of ocult blood without benzidine].
    Simon KH
    Med Monatsschr; 1970 Sep; 24(9):425-6. PubMed ID: 5515269
    [No Abstract]   [Full Text] [Related]  

  • 34. Benzidine: a carcinogen.
    Hsia YE
    N Engl J Med; 1969 Oct; 281(18):1020-1. PubMed ID: 5824736
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of detergents on chemical occult blood test.
    Imafuku Y; Yoshida H; Yoshida S
    Fukushima J Med Sci; 1999 Dec; 45(2):117-23. PubMed ID: 11039608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of juvenile iron deficiency with bivalent iron dragees (Fe2-fumarate, succinate, sulfate). Controlled double-blind study].
    Bender-Götze C
    Fortschr Med; 1980 Apr; 98(15):(590-3). PubMed ID: 7390366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Iron treatment by effervescent tablets (author's transl)].
    Picha E
    Geburtshilfe Frauenheilkd; 1975 Oct; 35(10):792-5. PubMed ID: 1102383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of occult blood in faeces.
    Garrick DP; Close JR; McMurray W
    Lancet; 1977 Oct; 2(8042):820-1. PubMed ID: 71626
    [No Abstract]   [Full Text] [Related]  

  • 39. Double-blind placebo-controlled evaluation of levamisole in chronic rheumatoid arthritis.
    Franchimont P; Heynen G; Berghs H; Remans J; Vroninks P
    Scand J Rheumatol; 1979; 8(1):43-8. PubMed ID: 373088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability of iron in oral ferrous sulfate preparations in healthy volunteers.
    Walker SE; Paton TW; Cowan DH; Manuel MA; Dranitsaris G
    CMAJ; 1989 Sep; 141(6):543-7. PubMed ID: 2776093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.